摘要
AIM:To evaluate the effect of RNA interference (RNAi) mediated silence of signal transduction and activation of transcription (STAT)3 on the growth of human pancreatic cancer cells both in vitro and in vivo.METHODS:STAT3 specific shRNA was used to silence the expression of STAT3 in pancreatic cancer cell line SW1990.The anti-growth effects of RNAi against STAT3 were studied in vitro and in experimental cancer xenografts in nude mice.The potential pathways involved in STAT3 signaling were detected using reverse transcription polymerase chain reaction and western blotting.RESULTS:The expression of the STAT3 was inhibited using RNAi in SW1990 cells.RNAi against STAT3 inhibited cell proliferation,induced cell apoptosis and significantly reduced the levels of CyclinD1 and Bcl-xL when compared with parental and control vector-transfected cells.In vivo experiments showed that RNAi against STAT3 inhibited the tumorigenicity of SW1990 cells and significantly suppressed tumor growth when it was directly injected into tumors.CONCLUSION:STAT3 signaling pathway plays an important role in the progression of pancreatic cancer,and silence of STAT3 gene using RNAi technique may be a novel therapeutic option for treatment of pancreatic cancer.
AIM： To evaluate the effect of RNA interference （RNAi） mediated silence of signal transduction and activation of transcription （STAT）3 on the growth of human pan- creatic cancer cells both in vitro and in vivo. METHODS： STAT3 specific shRNA was used to silence the expression of STAT3 in pancreatic cancer cell line SW1990. The anti-growth effects of RNAi against STAT3 were studied in vitro and in experimental cancer xenografts in nude mice. The potential pathways involved in STAT3 signaling were detected using reverse transcrip- tion polymerase chain reaction and western blotting.RESULTS： The expression of the STAT3 was inhibited using RNAi in SW1990 cells. RNAi against STAT3 inhib- ited cell proliferation, induced cell apoptosis and signif- icantly reduced the levels of CyclinD1 and Bcl-xl_ when compared with parental and control vector-transfected cells. In vivo experiments showed that RNAi against STAT3 inhibited the tumorigenicity of SW1990 cells and significantly suppressed tumor growth when it was directly injected into tumors.CONCLUSION： STAT3 signaling pathway plays an important role in the progression of pancreatic cancer, and si- lence ofSTAT3 gene using RNAi technique may be a novel therapeutic option for treatment of pancreatic cancer.
基金
Supported by A Grant from the Science and Technology Commission of Shanghai Municipality,No. 09QA1404600
a grant from the Affiliated First People’s Hospital of ShanghaiJiao Tong University,No. 0801
